Comparable stake leader
JANE STREET GROUP, LLC
SEC ownership of Co-Diagnostics, Inc.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001692415.
Disclosed value leader
Orca Capital AG
Comparable rows
18/27
Latest evidence
28 May 2026
- Public ticker
- CODX on Nasdaq
- Parsed ownership sources
- 13D/G, 13F, and 3/4/5
- Largest SEC-reported holder
- JANE STREET GROUP, LLC
- Latest 13D/G holder
- JANE STREET GROUP, LLC
- Latest parsed ownership date
- 28 May 2026
- Issuer CIK
- 0001692415
- Issuer location
- Salt Lake City, UT
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
2 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of Co-Diagnostics, Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
JANE STREET GROUP, LLC
Disclosed value leader
Orca Capital AG
Comparable rows
18/27
Latest evidence
28 May 2026
13D/G
13F
3/4/5
Lead comparable stake: 6.4%
9 rows are not safely comparable across share classes.
13D/G row: JANE STREET GROUP, LLC
Showing 1-8 of 27 holder rows.
Quick read
JANE STREET GROUP, LLC leads the comparable SEC ownership view at 6.4%.
18 of 27 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens JANE STREET GROUP, LLC's linked filing trail.
Comparable ownership
Top 5
JANE STREET GROUP, LLC
6.4%
Orca Capital AG
3.7%
VANGUARD GROUP INC
3.5%
Private Advisory Group LLC
1.1%
UBS Group AG
0.2%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 27 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| JANE STREET GROUP, LLC |
13D/G
|
6.4%
|
$378,174
236,359 shares
|
$0 | 28 May 2026 |
| Orca Capital AG |
13D/G
|
3.7%
|
$818,338
2,248,182 shares
|
+$19,827 | 28 Oct 2025 |
| VANGUARD GROUP INC |
13D/G
The Vanguard Group
|
3.5%
|
$620,967
1,705,952 shares
|
$0 | 30 Sep 2025 |
| Private Advisory Group LLC |
13F
Company
|
1.1%
|
$76,980
41,387 shares
|
— | 31 Mar 2026 |
| UBS Group AG |
13F
Company
|
0.2%
|
$13,705
7,368 shares
|
— | 31 Mar 2026 |
| Smartleaf Asset Management LLC |
13F
Company
|
0%
|
$226
133 shares
|
— | 31 Mar 2026 |
| MORGAN STANLEY |
13F
Company
|
0%
|
$164
88 shares
|
— | 31 Mar 2026 |
| WELLS FARGO & COMPANY/MN |
13F
Company
|
0%
|
$151
81 shares
|
— | 31 Mar 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 03 Jun 2025.
Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-10 of 10 reporting-owner rows connected to Co-Diagnostics, Inc.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
10
Largest Forms 3/4/5 holder
Ted Murphy
Net 12M change
$0
Latest report
27 May 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Ted Murphy | Director | $82,941 | Mixed | 13 Aug 2025 | ||
| Dwight H. Egan | Chief Executive Officer, Director | $51,961 | Median | 23 May 2026 | ||
| Brian L. Brown | Chief Financial Officer | $41,689 | Median | 23 May 2026 | ||
| Edward L. Murphy | Director | $20,648 | Median | 23 May 2026 | ||
| Richard S. Serbin | Director | $20,028 | Median | 23 May 2026 | ||
| Eugene Durenard | Director | $19,873 | Median | 27 May 2026 | ||
| James B. Nelson | Director | $19,873 | Median | 23 May 2026 | ||
| Richard David Abbott | President | $6,365 | Median | 23 May 2026 | ||
| Reed L. Benson | General Counsel | $3,994 | Mixed | 24 May 2021 | ||
| Brent Satterfield | Former Chief Science Officer | Mixed | 23 Feb 2021 |
Recent insider transactions for Co-Diagnostics, Inc.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Dwight H. Egan | CODX | Common Stock | Disposed to Issuer | -5.53% | -1,633 | 27,893 | 23 May 2026 | Direct | ||
| Dwight H. Egan | CODX | Common Stock | Award | 18.4% | 4,584 | 29,526 | 23 May 2026 | Direct | ||
| Dwight H. Egan | CODX | Restricted Stock Unit | Options Exercise | -33.3% | -4,584 | 9,166 | 23 May 2026 | Direct | ||
| Brian L. Brown | CODX | Common Stock | Disposed to Issuer | -5.69% | -1,350 | 22,379 | 23 May 2026 | Direct | ||
| Brian L. Brown | CODX | Common Stock | Award | 18.8% | 3,750 | 23,729 | 23 May 2026 | Direct | ||
| Brian L. Brown | CODX | Restricted Stock Unit | Options Exercise | -33.3% | -3,750 | 7,500 | 23 May 2026 | Direct | ||
| Richard David Abbott | CODX | Common Stock | Disposed to Issuer | -16.6% | -680 | 3,417 | 23 May 2026 | Direct | ||
| Richard David Abbott | CODX | Common Stock | Award | 85.6% | 1,890 | 4,097 | 23 May 2026 | Direct | ||
| Richard David Abbott | CODX | Restricted Stock Unit | Options Exercise | -19.3% | -1,890 | 7,903 | 23 May 2026 | Direct | ||
| Edward L. Murphy | CODX | Common Stock | Award | 18% | 1,695 | 11,084 | 23 May 2026 | Direct | ||
| Edward L. Murphy | CODX | Restricted Stock Unit | Options Exercise | -29.8% | -1,695 | 4,000 | 23 May 2026 | Direct | ||
| Richard S. Serbin | CODX | Common Stock | Award | 18.7% | 1,695 | 10,751 | 23 May 2026 | Direct | ||
| Richard S. Serbin | CODX | Restricted Stock Unit | Options Exercise | -29.8% | -1,695 | 4,000 | 23 May 2026 | Direct | ||
| Eugene Durenard | CODX | Common Stock | Award | 18.9% | 1,695 | 10,668 | 23 May 2026 | Direct | ||
| Eugene Durenard | CODX | Restricted Stock Unit | Options Exercise | -29.8% | -1,695 | 4,000 | 23 May 2026 | Direct | ||
| James B. Nelson | CODX | Common Stock | Award | 18.9% | 1,695 | 10,668 | 23 May 2026 | Direct | ||
| James B. Nelson | CODX | Restricted Stock Unit | Options Exercise | -29.8% | -1,695 | 4,000 | 23 May 2026 | Direct | ||
| Edward L. Murphy | CODX | Common Stock | Award | 25.6% | 57,499 | 281,666 | 23 Nov 2025 | Direct | ||
| Edward L. Murphy | CODX | Restricted Stock Unit | Options Exercise | -25.2% | -57,499 | 170,834 | 23 Nov 2025 | Direct | ||
| Brian L. Brown | CODX | Common Stock | Disposed to Issuer | -6.36% | -40,723 | 599,355 | 23 Nov 2025 | Direct | ||
| Brian L. Brown | CODX | Common Stock | Award | 26.5% | 134,167 | 640,078 | 23 Nov 2025 | Direct | ||
| Brian L. Brown | CODX | Restricted Stock Unit | Options Exercise | -28.4% | -134,167 | 337,500 | 23 Nov 2025 | Direct | ||
| Richard David Abbott | CODX | Common Stock | Disposed to Issuer | -20.6% | -17,200 | 66,202 | 23 Nov 2025 | Direct | ||
| Richard David Abbott | CODX | Common Stock | Award | 212% | 56,667 | 83,402 | 23 Nov 2025 | Direct | ||
| Richard David Abbott | CODX | Restricted Stock Unit | Options Exercise | -16.2% | -56,667 | 293,771 | 23 Nov 2025 | Direct | ||
| Dwight H. Egan | CODX | Common Stock | Disposed to Issuer | -6.21% | -49,575 | 748,252 | 23 Nov 2025 | Direct | ||
| Dwight H. Egan | CODX | Common Stock | Award | 25.7% | 163,333 | 797,827 | 23 Nov 2025 | Direct | ||
| Dwight H. Egan | CODX | Restricted Stock Unit | Options Exercise | -28.4% | -163,333 | 412,500 | 23 Nov 2025 | Direct | ||
| Richard S. Serbin | CODX | Common Stock | Award | 26.8% | 57,499 | 271,666 | 23 Nov 2025 | Direct | ||
| Richard S. Serbin | CODX | Restricted Stock Unit | Options Exercise | -25.2% | -57,499 | 170,834 | 23 Nov 2025 | Direct | ||
| Eugene Durenard | CODX | Common Stock | Award | 27.2% | 57,499 | 269,166 | 23 Nov 2025 | Direct | ||
| Eugene Durenard | CODX | Restricted Stock Unit | Options Exercise | -25.2% | -57,499 | 170,834 | 23 Nov 2025 | Direct | ||
| James B. Nelson | CODX | Common Stock | Award | 27.2% | 57,499 | 269,166 | 23 Nov 2025 | Direct | ||
| James B. Nelson | CODX | Restricted Stock Unit | Options Exercise | -25.2% | -57,499 | 170,834 | 23 Nov 2025 | Direct | ||
| Richard David Abbott | CODX | Restricted Stock Units | Award | 168.7% | 220,000 | 350,438 | 13 Aug 2025 | Direct | ||
| Brian L. Brown | CODX | Restricted Stock Units | Award | 91.2% | 225,000 | 471,667 | 13 Aug 2025 | Direct | ||
| Dwight H. Egan | CODX | Restricted Stock Units | Award | 91.4% | 275,000 | 575,833 | 13 Aug 2025 | Direct | ||
| Eugene Durenard | CODX | Restricted Stock Units | Award | 121% | 125,000 | 228,333 | 13 Aug 2025 | Direct | ||
| James B. Nelson | CODX | Restricted Stock Units | Award | 121% | 125,000 | 228,333 | 13 Aug 2025 | Direct | ||
| Richard S. Serbin | CODX | Restricted Stock Units | Award | 121% | 125,000 | 228,333 | 13 Aug 2025 | Direct | ||
| Ted Murphy | CODX | Restricted Stock Units | Award | 121% | 125,000 | 228,333 | 13 Aug 2025 | Direct |
* marks a reported price that did not pass the local price check.